Surface plasmon resonance analysis of free IgE in allergic patients receiving omalizumab (Xolair)

Journal of Immunological Methods

Volumn 383, Issue 1-2, 2012, Pages 54-59

  Hamilton, Robert G ^a   Saini, Sarbjit S ^a   MacGlashan, Donald ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allergen specific; Free IgE; Human; IgE; Omalizumab; Xolair

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; OMALIZUMAB;

ALLERGY; ANALYTIC METHOD; ARTICLE; CLINICAL LABORATORY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; MICROTITER PLATE ASSAY; MONITORING; PRIORITY JOURNAL; PROVOCATION TEST; QUANTITATIVE ANALYSIS; RISK REDUCTION; SENSITIZATION; SKIN TEST; SURFACE PLASMON RESONANCE;

ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL, HUMANIZED; BALTIMORE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOTHERAPY; MONITORING, IMMUNOLOGIC; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SURFACE PLASMON RESONANCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84864384901     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2012.05.015     Document Type: Article

References (20)

1. Bernstein I.L., Li J.T., Bernstein D.I., Hamilton R.G., Spector S.L., Tan R., Sicherer S., Golden D.B., Khan D.A., Nicklas R.A., Portnoy J.M., Blessing-Moore J., Cox L., Lang D.M., Oppenheimer J., Randolph C.C., Schuller D.E., Tilles S.A., Wallace D.V., Levetin E., Weber R., American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology Allergy diagnostic testing: an updated practice parameter. Ann. Allergy Asthma Immunol. 2008, 100:S1.
2. Chang T.W., Davis F.M., Sun N.C., Sun C.R., MacGlashan D.W., Hamilton R.G. Monoclonal antibodies specific for human IgE-producing B cells: a potential therapeutic for IgE-mediated allergic diseases. Biotechnology (N. Y.) 1990, 8:122.
3. Christensen L.H., Holm J., Lund G., Riise E., Lund K. Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge. J. Allergy Clin. Immunol. 2008, 122:298.
4. Cox L., Williams B., Sicherer S., Oppenheimer J., Sher L., Hamilton R.G., Golden D., American College of Allergy, Asthma and Immunology, American Academy of Allergy, Asthma, Immunology Specific IgE Test Task Force Pearls and pitfalls of allergy diagnostic testing: Report from the American College of Allergy, Asthma and Immunology/American Academy of Allergy, Asthma and Immunology Specific IgE Test Task Force. Ann. Allergy Asthma Immunol. 2008, 101:580.
5. Eckman J.A., Sterba P.M., Kelly D., Alexander V., Liu M.C., Bochner B.S., MacGlashan D.W., Saini S.S. Effects of Omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge. J Allergy Clin Immunol 2010, 125:889.
6. Garman S.C., Wurzburg B.A., Tarchevskaya S.S., Kinet J.P., Jardetzky T.S. Structure of the Fc fragment of human IgE bound to its high affinity receptor Fc epsilon RI alpha. Nature 2000, 406:259.
7. Golden D.B., Moffitt J., Nicklas R.A., Freeman T., Graft D.F., Reisman R.E., Tracy J.M., Bernstein D., Blessing-Moore J., Cox L., Khan D.A., Lang D.M., Oppenheimer J., Portnoy J.M., Randolph C., Schuller D.E., Spector S.L., Tilles S.A., Wallace D., Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma & Immunology (AAAAI), American College of Allergy, Asthma & Immunology (ACAAI) Joint Council of Allergy, Asthma and Immunology. Stinging insect hypersensitivity: a practice parameter update 2011. J Allergy Clin Immunol 2011, 127:852.
8. Hamilton R.G. Accuracy of US Food and Drug Administration-cleared IgE antibody assays in the presence of anti-IgE (omalizumab). J. Allergy Clin. Immunol. 2006, 117:759.
9. Hamilton R.G. Clinical laboratory assessment of immediate-type hypersensitivity. J. Allergy Clin. Immunol. 2010, 125:S284.
10. Hamilton R.G., Brown R.H. Impact of Personal Avoidance Practice on Healthcare Workers Sensitized to Natural Rubber Latex. J. Allergy Clin. Immunol. 2000, 105:839.
11. Hamilton R.G., Eggleston P.A. Environmental allergen analyses. Methods 1997, 13:53.
12. Hamilton R.G., Marcotte G.V., Saini S.S. Immunological methods for quantifying free and total serum IgE in asthma patients receiving Omalizumab (Xolair) therapy. J. Immunol. Methods 2005, 303:81.
13. Hamilton R.G., MacGlashan D.W., Saini S.S. IgE antibody-specific activity in human allergic disease. Immunol. Res. 2010, 47:273.
14. Henry A.J., Cook J.P., McDonnell J.M., Mackay G.A., Shi J., Sutton B.J., Gould H.J. Participation of the N-terminal region of C-epsilon 3 in the binding of human IgE to its high affinity receptor Fc-epsilon RI. Biochemistry 1997, 36:15568.
15. Jarvinen, K.M., Sicherer, S.H., in press. Diagnostic oral food challenges: procedures and biomarkers. J. Immunol. Meth.
16. Liu J., Lester P., Builder S., Shire S.J. Characterization of complex formation by humanized anti-IgE monoclonal antibody and monoclonal human IgE. Biochemistry 1995, 34:10474.
17. MacGlashan D.W., Bochner B.S., Adelman D.C., Jardieu P.M., Togias A., Mckenzie-White J., Sterbinsky S.A., Hamilton R.G., Lichtenstein L.M. Down-regulation of FceR1 expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J. Immunol. 1997, 158:1438.
18. MacGlashan D.W., Xia H.Z., Schwartz L.B., Gong J.P. IgE-regulated expression of FceR1 in human basophils: Control by regulated loss rather than regulated synthesis. J. Leukoc. Biol. 2001, 70:207.
19. Saini S.S., MacGlashan D.W., Strebinsky S.A., Togias A., Adelman D.C., Lichtenstein L.M., Bochner B.S. Down-regulation of human basophil IgE and FcεRIa surface density and mediator release by anti-IgE infusions in reversible in vitro and in vivo. J. Immunol. 1999, 12:5623.
20. Zaidi A.K., Saini S.S., MacGlashan D.W. Regulation of Syk kinase and FcR beta expression in human basophils during treatment with Omalizumab. J. Allergy Clin. Immunol. 2010, 125:902.